Latest Breaking News On - Maximum tolerated dose reached - Page 1 : vimarsana.com

Issuer: Immunic, Inc. / Key word(s): Study results Immunic Announces Positive Results from Single and Multiple Ascending Dose Parts of Its Phase 1 Clinical Trial of IMU-856 in Healthy Human

New zealandEdna kaplanPaula schwartzJessica breuDaiichi sankyoAndreas muehlerDaniel vittExchange commissionDaiichi sankyo co ltdRx communications groupImmunic incDistribution servicesAnnounces positive resultsMultiple ascending dose partsIts phaseHealthy human subjects